Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses

Journal of Immunology

Volumn 162, Issue 9, 1999, Pages 5536-5546

  Smith, Rosemary E ^a   Donachie, Anne M ^a   Grdic, Dubravka ^b   Lycke, Nils ^b   Mowat, Allan McI ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 6; ISCOM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; QUIL A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KNOCKOUT MOUSE; MAST CELL; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ASCITIC FLUID; CELL MOVEMENT; CYTOKINES; EPITOPES; FEMALE; IMMUNITY, NATURAL; IMMUNOPHENOTYPING; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-12; ISCOMS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; OVALBUMIN; REACTIVE OXYGEN SPECIES; SAPONINS;

EID: 0033136324     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Bloom, B. R. 1989. Vaccines for the Third World. Nature 342:115.
2. Mowat, A. McI., A. M. Donachie, G. Reid, and O. Jarrett. 1991. Immune-stimulating complexes containing Quil-A and protein antigen prime class-I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology 72:317.
3. Gupta, R. K., and G. R. Siber. 1995. Adjuvants for human vaccines: current status, problems and future prospects. Vaccine 13:1263.
4. Harokopakis, E., G. Hajishengallis, T. E. Greenway, M. W. Russell, and S. M. Michalek. 1997. Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits. Infect. Immun. 65:1445.
5. Hornquist, E., N. Lycke, and C. Czerkinsky. 1994. Cholera toxin and cholera B subunit as oral mucosal adjuvant and antigen carrier systems. In Novel Delivery Systems for Oral Vaccines. D. T. O'Hagan, ed. CRC Press, Boca Raton.
6. Douce, G., C. Trucotte, I. Cropley, M. Roberts, M. Pizza, M. Domenighini, R. Rappuoli, and G. Dougan. 1995. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc. Natl. Acad. Sci. USA 92:1644.
7. Levine, M., J. Kaper, R. Black, and M. Clements. 1983. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol. Rev. 47:510.
8. Lovgren, K., and B. Morein. 1988. The requirement of lipids for the formation of immunostimulating complexes (ISCOMS). Biotechnol. Appl. Biochem. 10:161.
9. Kazanji, M., F. Laurent, and P. Pery. 1994. Immune-responses and protective effect in mice vaccinated orally with surface sporozoite protein of Eimeria-falciformis in ISCOMS. Vaccine 12:798.
10. Estrada, A., B. Laarveld, B. Li, and M. J. Redmond. 1995. Induction of systemic and mucosal immune-responses following immunisation with somatostatin avidin complexes incorporated into ISCOMS. Immun. Invest. 24:819.
11. + T-cell responses by oral or parenteral immunisation with ISCOMS. Eur. J. Immunol. 25:2835.
12. Morein, B. 1990. ISCOMS. Vet. Microbiol. 23:79.
13. + cytotoxic T-lymphocytes towards soluble-antigens: immunostimulating-ovalbumin complexes enter the class-I MHC-restricted antigen pathway and allow sensitisation against the immunodominant peptide. Eur. J. Immunol. 21:1523.
14. Mowat, A. McI., K. J. Maloy, and A. M. Donachie. 1993. Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunisation with protein antigens. Immunology 80:527.
15. Watson, D. L., K. Lovgren, N. A. Watson, C. Fossum, B. Morein, and S. Hoglund. 1989. Inflammatory response and antigen localization following immunization with influenza-virus ISCOMS. Inflammation 13:641.
16. Villacres-Eriksson, M., M. Bergstrom-Mollaoglu, H. Kaberg, K. Lovgren, and B. Morein. 1993. The induction of cell-associated and secreted IL-1 by ISCOMS, matrix or micelles in murine splenic cells. Clin. Exp. Immunol. 93:120.
17. Behboudi, S., B. Morein, and M. Villacres-Eriksson. 1997. In vivo and in vitro induction of IL-6 by Quillaja saponaria Molina triterpenoid formulations. Cytokine 9:682.
18. Villacres-Eriksson, M., S. Behboudi, A. J. Morgan, G. Trinchieri, and B. Morein. 1997. Immunomodulation by Quillaja saponaria adjuvant formulations: in vivo stimulation of interleukin 12 and its effects on the antibody response. Cytokine 9:73.
19. Xu, D., W. L. Chan, F.-P. Huang, R. Wheeler, D. Piedrafita, J. H. Robinson, and F. Y. Liew. 1998. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 187:787.
20. Piedrafita, D., L. Proudfoot, A. V. Nikoleav, D. Xu, W. Sands, G.-J. Feng, E. Thomas, J. Brewer, M. A. J. Ferguson, J. Alexander, et al. 1999. Regulation of macrophage IL-12 synthesis by Leishmania proteoglycans. Eur. J. Immunol. 29:235.
21. Easmon, C. S. F., P. J. Cole, A. J. Williams, and M. Hastings. 1980. The measurement of opsonic and phagocytic function by Luminol-dependent chemiluminescence. Immunology 41:67.
22. Watson, D. L., N. A. Watson, C. Fossum, K. Lovgren, and B. Morein. 1992. Interactions between immune-stimulating complexes (ISCOMS) and peritoneal mononuclear leukocytes. Microbiol. Immunol. 36:199.
23. Church, M. K., and F. Levi-Schaffer. 1997. The human mast cell. J. Allergy Clin. Immunol. 99:155.
24. Gordon, J. R., P. R. Burd, and S. J. Galli. 1990. Mast cells as a source of multifunctional cytokines. Immunol. Today 11:458.
25. Maloy, K. 1996. The basis of the oral and parenteral adjuvant properties of immune stimulating complexes (ISCOMS). Doctoral Dissertation, University of Glasgow, Glasgow, Scotland.
26. Kovacsovics-Bankowski, M., and K. Rock. 1995. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267: 243.
27. Albert, M., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86.
28. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.
29. Behboudi, S., B. Morein, and M. Villacres-Eriksson. 1996. In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja-saponaria Molina triterpenoids. Clin. Exp. Immunol. 105:26.
30. Baumann, H., and J. Gauldie. 1994. The acute phase response. Immunol. Today 15:74.
31. Ramsay, A. J., A. J. Husband, I. A. Ramshaw, S. Bao, K. I. Matthaei, G. Koehler, and M. Kopf. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264:561.
32. + T helper cell 1 development in interleukin-6-deficient mice infected with Candida albicans. J. Exp. Med. 183:1345.
33. Wei, X.-Q., I. G. Charles, A. Smith, J. Ure, G.-J. Feng, F. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408.
34. + natural killer cells stimulated with interleukin-2, inlerleukin-7 and interleukin-12. Eur. J. Immunol. 23:1831.
35. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
36. Abdi, K., and S. H. Herrmann. 1997. CTL generation in the presence of IL-4 is inhibited by free p40: evidence for early and late IL-12 function. J. Immunol. 159:3148.
37. Robertson, M. J., R. J. Soiffer, S. F. Wolf, T. J. Manley, C. Donahue, D. Young, S. H. Herrman, and J. Ritz. 1992. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 175:779.
38. + NK cells. J. Immunol. 148:2429.
39. Smith, R. E., A. M. Donachie, F. H. McLaren, and A. McI. Mowat. 1998. Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of interleukin-4 or interferon-γ. Immunology 93:556.
40. Scharton-Kersten, T. M., T. A. Wynn, E. Y. Denkers, S. Bala, E. Grunvald, S. Hieny, R. T. Gazzinelli, and A. Sher. 1996. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045.
41. Li, C., J. M. Goodrich, and X. Yang. 1997. Interferon-γ (IFN-γ) regulates production of IL-10 and IL-12 in human herpes virus-6 (HHV-6)-infected monocyte/macrophage lineage. Clin. Exp. Immunol. 109:421.
42. Micallef, M. J., T. Ohtsuki, K. Kohno, F. Tanabe, S. Ushio, M. Namba, T. Tanimoto, K. Torigoe, M. Fuji, M. Ikeda, et al. 1996. Interferon-γ-inducing factor enhances T-helper-1 cytokine production by stimulated human T-cells: synergism with interleukin-12 for interferon-γ production. Eur. J. Immunol. 26:1647.
43. Zhang, T. T., K. Kawakami, M. H. Qureshi, H. Okamura, M. Kurimoto, and A. Saito. 1997. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of γ interferon by natural killer cells. Infect. Immun. 65:3594.
44. Kensil, C. R. 1996. Saponins as vaccine adjuvants. Crit. Rev. Ther. Drug Carrier Syst. 13:1.
45. Smith, R. E., K. J. Maloy, A. M. Donachie, and A. McI. Mowat. 1998. Immune stimulating complexes as mucosal adjuvants. Immunol. Cell Biol. 76:263.
46. Bengtsson, K. L., and A. Sjolander. 1996. Adjuvant activity of ISCOMS; effect of ratio and co-incorporation of antigen and adjuvant. Vaccine 14:753.